Drugs / Vinpocetine
Vinpocetine
also known as
Apovincaminic acid ethyl ester · AY-27,255 · Bravinton · Cavinton · Ceractin · Ethyl apovincamin-22-oate · NSC-760093 · Rgh 4405 · +5 more
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06635746 | Jun 2025 → Jun 2026 overdue | fetal alcohol spectrum disorder | Stanford University | Not yet recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06441591 | Jul 2024 → Jun 2025 overdue | diabetic kidney disease | Ain Shams University | Recruiting | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02011971 Comparator | Feb 2012 → Dec 2026 | epilepsy | Stanford University | Suspended | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT07229664 Comparator | Nov 2025 → Nov 2026 expected | Parkinson disease | Tanta University | Recruiting | No outcome recorded |
| Phase 2/3 | NCT02878772 Comparator | May 2014 → Dec 2015 | ischemic stroke | Tianjin Medical University General Hospital | Completed | No outcome recorded |
Evidence & citations 17 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vinpocetine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07229664 ↗ |
| Known as | Apovincaminic acid ethyl ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | AY-27,255 | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Bravinton | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Cavinton | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Ceractin | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Ethyl apovincamin-22-oate | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | NSC-760093 | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Rgh 4405 | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Tcv 3b | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Ultra-vinca | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | VIN | “VIN, a phosphodiesterase-1 (PDE1) inhibitor, reduces oxidative stress and neuroinflammation and is used clinically for cerebrovascular disease and dementia.” NCT07229664 ↗ |
| Known as | Vinpocetina | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Known as | Vinporal | ChEMBL registry synonym — accepted as the source's own label CHEMBL71752 ↗ |
| Action | Inhibit | “is a selective inhibitor of phosphodiesterase type 1 (PDE1)” NCT06441591 ↗ |
| Modality | Small molecule | “Vinpocetine is a chemical obtained from the leaves of the Lesser Periwinkle.” NCT02011971 ↗ |
| Route | Oral | “acute oral doses of vinpocetine” NCT02011971 ↗ |